Delayed
Research every ETF. Compare everything.
★
Menu
All ETFs Screener Rankings International Compare News
Browse Categories Sectors Issuers Holdings & Stocks Performance Heat Map Fund Overlap New Launches
Rankings Highest Yield Best Performing Largest ETFs Most Active Trending Lowest Fees All Rankings
International Emerging Markets Developed Markets Europe Asia-Pacific Currency Hedged International Hub
Learn & Tools Learn Ask the Data AI Agents ★ Saved API
About About us Contact Disclaimer
Members
API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets? Prices, yields, YTD, market cap: we explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language

XDNA Kelly CRISPR & Gene Editing Technology ETF

7.38 -0.12 (-1.60%)

Quote as of Nov 30, 2023 16:51 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.

Compare Overlap News
Previous Close7.50 Day Range7.38 – 7.55
52-Week Range5.87 – 11.83 Volume4.25K
Avg Volume5.04K AUM$2.6M (Oct 10, 2026)
Expense Ratio0.78% Yield (TTM)—
NAV7.38 Premium/Discount0.00% indicative
InceptionJan 13, 2022 Holdings1
IssuerKellyETFs ExchangeNASDAQ
CategoryTechnology Index TrackedNot stated in source data
CUSIP46437W105 ISINCA46437W1059
ManagementNot stated in source data

About this ETF

The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.

Description from the fund data provider · profile as of Oct 10, 2026.

Price Chart

Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.

Performance

1M3M6MYTD1Y3Y*5Y*10Y*Incep.*
Price return +15.67% -9.00% -21.66% -25.75% -32.79% — — — -28.96%
Total return +15.67% -9.00% -21.66% -25.75% -32.73% — — — -28.94%

* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Dec 13, 2023. Past performance does not guarantee future results.

Fees

Net expense ratio0.78% Annual cost of a $10,000 investment$78.00

Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.

Holdings

Holdings as of Dec 01, 2023 · portfolio reporting date from the data provider; holdings are not live positions. 1 rows in database.

#HoldingTickerWeightSharesMarket Value
1 Cash & Other — 100.00% 2.58M $2.6M

Click a ticker to see every ETF that owns it.

Sector Exposure

Cash & Others 100.00%

Distributions

Yield (TTM)— Paid (last 12 months)—
FrequencyIrregular SEC yieldNot provided by our data source; see the issuer page
Last ex-dateDec 22, 2022 Last payment$0.0093 (Dec 27, 2022)
Growth 1Y— Growth 3Y / 5Y (ann.)— / —
Ex-dateRecordPay dateAmount
Dec 22, 2022Dec 23, 2022 Dec 27, 2022$0.0093

Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →

Risk Statistics

Risk statistics need at least a year of price history; not yet available for this fund.

Liquidity

Volume today4.25K Average volume5.04K
AUM$2.6M Premium/Discount0.00%
Bid/Ask spreadNot provided by our data source. Check your broker's quote screen; spreads are widest at the open and close.

Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →

Official Fund Resources

External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.

Latest News for XDNA

No articles mention this fund directly in the last 7 days; showing general ETF coverage.

Forget T-Bills. These Box Spread ETFs Pay the Same Rate With Minimal Taxable Yield ↗ Treasury bills look tempting right now, but a growing category of options-based ETFs promises a similar yield while keeping the IRS largely out of… 24/7 Wall Street · Oct 10, 22:20 UTC Ethereum ETFs Have Had Nine Straight Days of Outflows and Lost $2 Billion in Assets. Is Wall Street Giving Up on ETH? ↗ Ethereum ETFs just logged nine straight sessions of outflows and shed nearly $2 billion in assets, but the real story behind those numbers tells a… 24/7 Wall Street · Oct 10, 18:35 UTC Forget JEPI: Goldman's Income Fund Held Its Payment Steady While JEPI's Shrank ↗ JEPI has dominated the covered-call income space for years, but a younger Goldman Sachs rival has been quietly outpacing it on both total return and… 24/7 Wall Street · Oct 10, 16:03 UTC How Much Does a 57-Year-Old Need in a Roth IRA to Collect $5,050 a Month Tax-Free for Life? ↗ A seven-fund Roth portfolio built around option income, private lending, and net-lease rent can generate $60,000 a year tax-free, but a 57-year-old… 247 Wallst · Oct 10, 13:29 UTC Could Buying This 1 Cryptocurrency Make You Rich? ↗ NEAR Protocol is soaring in value this year, but how long can it keep up this performance? Fool - Investing News · Oct 10, 12:28 UTC Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma ↗ BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their… Fool - Investing News · Oct 10, 12:19 UTC
All news for XDNA →

Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.

Commodity

Commodities (broad)GoldOil & GasSilver

Digital Assets

CryptocurrencyBitcoin

Fixed Income

Bonds (all)Government BondsTreasury BondsCorporate BondsHigh Yield BondsMunicipal BondsInternational BondsTIPS / Inflation-Protected

Income

DividendCovered Call / Option IncomePreferred Stocks

Region

InternationalGlobalDeveloped MarketsEmerging MarketsInternational Small CapFrontier Markets

Sector & Theme

FinancialsTechnologyEnergyReal Estate / REITsHealthcareIndustrialsMaterialsInfrastructureClean Energy

Strategy

Buffer / Defined OutcomeESG / SustainableCurrency HedgedMomentumEqual WeightLow Volatility

Structure

Active ETFsLeveragedInverse

Style & Size

U.S. Large CapGrowthValueU.S. Small CapU.S. Mid CapTotal Market